Last reviewed · How we verify
Local-Tax Trial: Local Intracoronary Administration of Paclitaxel After Stent Implantation for Prevention of Restenosis in Comparison With Stent Implantation Alone and With Implantation of a Paclitaxel-Eluting Stent
The aim of the study is to examine the efficacy of Paclitaxel injection after a stent implantation in patients with stenosis in native coronary arteries to prevent restenosis in comparision with two admitted therapies.
Details
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Phase | Phase 3 |
| Status | UNKNOWN |
| Enrolment | 204 |
| Start date | 2005-08 |
| Completion | 2007-07 |
Conditions
- Stable or Unstable Angina Pectoris
- Myocardial Ischemia
Interventions
- local intracoronary dosis of Paclitaxel
Primary outcomes
- The primary objective is the angiographical determination of the late lumen loss in the stent and/or persistent area, 6 month after stent implantation. — week 26 +/- 14 days
Countries
Germany